What's Hot
View all perspectives
Richard Conway RichardPAConway
3 years 1 month ago
ORAL Surveillance VTE risk. Significant increase in VTE/PE only at 10mg bd dose. Abstr#1941 #ACR21 @RheumNow https://t.co/WW71syiINE
Dr. John Cush RheumNow
3 years 1 month ago
Sick Leave in axSpA: Who takes more?
Dr. Rachel Tate ( @uptoTate) reviews abstract 0380 presented at #ACR21.
https://t.co/e8cU9rIVB1 https://t.co/ImSjjLK15m
TheDaoIndex KDAO2011
3 years 1 month ago
@drhalafadhil @ACRheum @nighat @DrDavidKarp (ACR President) who can we contact at ACR who can help mentor her? I believe there is session #GlobalRheumatologySummit that addresses this. @rheumnow #ACR21 #RheumatologyforAll
Janet Pope Janetbirdope
3 years 1 month ago
Nature or nurture or both? Genesis #scleroderma US cohort showed Hispanic pts had more RNP, more #SLE overlap & younger but ⬆️mortality vs whites but less mortality vs blacks. Health disparities? Abst#1839 #ACR21 @RheumNow https://t.co/pgYJEXP1fN
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 1 month ago
#ACR21 #Abstr1913 What do our patients think about #Telemedicine?GRA Registry (N=596; 50% RA and #lupus):
💠Most found => effective than In-Person
💠25% dissatisfied and not keen to continue post-COVID
💠Poor predictors: Age, 🇬🇧🇨🇦🇦🇺🇳🇿, Graduates @RheumNow
https://t.co/55UmppwF9P https://t.co/9AyYB4hI3V
Dr. John Cush RheumNow
3 years 1 month ago
Guselkumab in Psoriatic Arthritis
Dr. Pedro Castillo ( @_Castillo_Pedro) discuss three abstracts presented at #ACR21 that expand on the use of guselkumab for use with psoriatic arthritis.
https://t.co/hAbLTU4epW https://t.co/p33p6iysjX
TheDaoIndex KDAO2011
3 years 1 month ago
It was real...
no sugar coating...
the pandemic was tough...
But no match for these women!
You can watch on demand.
@ACRrheum #ACR21 @rheumnow @bmsnews https://t.co/M4YegqJ5mt
Robert B Chao, MD doctorRBC
3 years 1 month ago
Should we be measuring drug levels in pts taking infliximab?
⭐️Drug monitoring vs. standard dosing showed 73% sustained control vs. 55% (RA, PsA, SpA, UC, Crohn's, PsO)
#ACR21
Abs#1946
#ACRBest @RheumNow
https://t.co/sWMen50ljP https://t.co/F4Wpqis3id
Pedro Castillo _Castillo_Pedro
3 years 1 month ago
Prospective study of PsO screened @ derm clinics
🔹PsO➕>3 mo back pain starting <45yo➕no biologics➡️rheum ref, 100 pts seen➡️19 dx'ed as:
🔹14 axPsA, 68% met axSpA ASAS, 11/14 w/o pPsA
🔹5 pPsA w/o axial dz
https://t.co/azoks5CHCP
#ACR21 Abst#1796 @RheumNow
Janet Pope Janetbirdope
3 years 1 month ago
Anti-MAA Ab is not ‘baa’ humbug. In prevalent #RheumatoidArthritis, + MAA Ab was predictive of developing #RA #ILD. ? Novel biomarker. Needs validation but nice convincing data @RheumNow #ACR21 #ACRBest abst#1916 https://t.co/wuTPzSIsey
Eric Dein ericdeinmd
3 years 1 month ago
#ACR21 2022 ACR/EULAR MPA Criteria
▶️Classification, NOT diagnostic!
⭐️Clinical: negative for nasal GPA symptoms
⭐️Lab: +6 for pANCA or MPO, negative for cANCA/PR3 or eosinophilia
@RheumNow https://t.co/6YWmabNzuH https://t.co/XVzBF2KONp
Poster Hall